Drug Discovery & Development | Whitepapers & Reports
Axion Biosystems: Antibody-dependent Cellular Cytotoxicity of Natural Killer Cells
06 April 2023
Trastuzumab promotes natural killer cell activation through antibody-dependent cellular cytotoxicity (ADCC).
Subscribe to our newsletter
Sign up for our monthly Newsletter to keep up with all things NextGen Biomed